Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by realtyon Jun 24, 2020 11:27am

106 Views

Post# 31185864

RE:RE:RE:The last patient update was September 30, 2019

Again, they can provide an update as to how the first treatment went. They can provide an update on new patients being enrolled. They can provide an update on patients from the first trial. They can provide an update on progress for new sites. Here you all are defending the company, but dont you think that if there were more news that this may gain some additional interest in a larger Pharma Company being interested? Huh, strange how the company doesnt want anyone to know what is going on.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments